✦ LIBER ✦

Clinical considerations for biosimilar antibodies

✍ Scribed by Mellstedt, Håkan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biosimilar Safety Considerations in Clin

✍ Choy, Edwin; Jacobs, Ira Allen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 879 KB

Biosimilars 101: considerations for U.S.

✍ Camacho, Luis H.; Frost, Craig P.; Abella, Esteban; Morrow, Phuong K.; Whittaker 📂 Article 📅 2014 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 242 KB

Scientific considerations for assessing

✍ Shein-Chung Chow; Jun Wang; Laszlo Endrenyi; Peter A. Lachenbruch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Assessing immunogenicity of biosimilar t

✍ Chamberlain, Paul 📂 Article 📅 2013 🏛 Future Science 🌐 English ⚖ 684 KB

Statistical considerations in biosimilar

✍ Yulan Li; Qing Liu; Patricia Wood; Anandhi Johri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Setting the stage for biosimilar monoclo

✍ Schneider, Christian K; Vleminckx, Camille; Gravanis, Iordanis; Ehmann, Falk; Tr 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB